BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Gastroenterol. Mar 28, 2025; 31(12): 99846
Published online Mar 28, 2025. doi: 10.3748/wjg.v31.i12.99846
Table 1 Clinical characteristics of the two groups, n (%)

Normal LES-IRP group (n = 71)
Increased LES-IRP group (n = 410)
P value
Sex, male/female (n)37/34172/2380.111
Age, median (Q1-Q3) (years)45.0 (35.0-57.0)43.0 (33.0-54.0)0.134
BMI, median (Q1-Q3) (kg/m2)21.5 (19.1-23.8)20.9 (19.2-23.7)0.543
Duration of symptoms,
median (Q1-Q3) (months)
72.0 (24.0-180.0)36.0 (24.0-84.0)0.006
Previous treatment21 (29.5)59 (14.4)0.002
    Balloon dilation10 (14.1)30 (7.3)
    Botox injection2 (2.8)16 (3.9)
    Temporary stenting1 (1.4)6 (1.5)
    Heller myotomy4 (5.6)2 (0.5)
    POEM1 (1.4)2 (0.5)
    Balloon dilation + botox injection1 (1.4)2 (0.5)
    Balloon dilation + temporary stenting2 (2.8)1 (0.2)
Pre-treatment HRM
    LES basal pressure, median (Q1-Q3) (mmHg)14.8 (12.0-20.3)32.3 (23.7-41.8)0.000
    LES-IRP, median (Q1-Q3) (mmHg)11.4 (9.2-12.5)25.7 (20.3-32.3)0.000
Ling classification0.014
    Type Ling I7 (9.9)84 (20.5)
    Type Ling IIa21 (29.6)142 (34.6)
    Type Ling IIb17 (23.9)105 (25.6)
    Type Ling IIc22 (31.0)66 (16.1)
    Type Ling III4 (5.6)13 (3.2)


Write to the Help Desk